"PROOF That Putin Is A NWO PUPPET - WEF 2008, Schwab Interview!!! Russia/WW3 Is a NWO Set Up Folks!!!"
"Merkel, Tony Blair, even President Putin- they were all young global leaders"- Klaus Schwab Davos 2019 to Costa Rica President Alvarado Quesada (Costa Rica mandated children get vaxd)
2:30 min
https://www.bitchute.com/video/ycvtBhjrheTE/
www.dasforum-derfilm.de
trips on dubs
it is a slave plantation like all other corporation/nations. One plot of the global human livestock plantation.
>Bahhh
https://www.msn.com/en-us/health/medical/human-organoids-and-mysterious-class-of-proteins-among-topics-for-new-allen-investigators/ar-AATEXRF
Human ‘organoids’ and mysterious class of proteins among topics for new Allen Investigators
The Paul G. Allen Frontiers Group, a division of Seattle’s Allen Institute, has announced a new crop of 11 award-winning projects in biology and medicine.
The awards aim to support early-stage projects in research in areas that are overlooked by traditional research funding programs. The group will provide $1.3 to $1.5 million to each of the projects, supporting 23 new Allen Distinguished Investigators.
This year’s awards focus on three areas of research: the design of neural circuits, the role of tiny “micropeptides” in immunity, and harnessing synthetic biology in human tissue research, for instance to build mini-organs resembling human brains or livers.
The late Microsoft co-founder Paul Allen initiated the Allen Distinguished Investigator program in 2010. The program has funded a total of 105 investigators, including this year’s awardees. This year’s cohort is supported by $15.5 million in total from the Paul G. Allen Family Foundation.
The investigators will be funded for three years. Here’s a run-down of the research.
The awards aim to support early-stage projects in research in areas that are overlooked by traditional research funding programs. The group will provide $1.3 to $1.5 million to each of the projects, supporting 23 new Allen Distinguished Investigators.
This year’s awards focus on three areas of research: the design of neural circuits, the role of tiny “micropeptides” in immunity, and harnessing synthetic biology in human tissue research, for instance to build mini-organs resembling human brains or livers.
The late Microsoft co-founder Paul Allen initiated the Allen Distinguished Investigator program in 2010. The program has funded a total of 105 investigators, including this year’s awardees. This year’s cohort is supported by $15.5 million in total from the Paul G. Allen Family Foundation.
The investigators will be funded for three years. Here’s a run-down of the research.
Researchers will map the neural connections in the octopus arm; study the nervous system in the larvae of a fruit fly species that jumps high in the air, and compare it to a related species that doesn’t have that ability; and examine the nervous system of ctenophores, evolutionary ancient marine animals that resemble jellyfish.
The research groups involved in these three projects are located at San Francisco State University, the Francis Crick Institute and the Whitney Laboratory for Marine Bioscience.
Micropeptides and immunity: A recently-discovered class of molecules in the body, called “micropeptides.” appear to be present in every living thing in large numbers, but little is known about their function.
Researchers will examine these molecules in the human gut microbiome; investigate their role in the immune system of humans and fruit flies; and assess their ability to “wake up” sleeping viruses in the human body, potentially spurring autoimmune disease.
The research groups involved in these three projects are located at Stanford; Yale University; and The Rockefeller University and CUNY Hunter College.
Synthetic biology advances for human tissues: Five projects in this area will focus liver, lungs, brain, connective tissue, and other human tissues.
Projects include studying how to grow more life-like brain organoids, lab-grown brain-like structures derived from human stem cells. Another project aims to recreate the complex branching of lung tissue through genetic engineering of stem cells. And a third is investigating a new type of supportive tissue that could help improve the three-dimensional of organoids in a petri dish. These projects will take place at KU Leuven, Belgium; Boston University; and the Whitehead Institute for Biomedical Research.
Another project is assessing how human livers develop, with the ultimate aim of growing new organs in the lab. That project will be led by University of Washington assistant professor of laboratory medicine and pathology Kelly Stevens.
A fifth project will involve researchers at the University of British Columbia. The investigators will trace the lineage of stem cells as they divide and form organoids — when do they divide, and what do the cells turn into? The team is also working on ways to grow blood vessels in organoids. The project will be led by new Allen Distinguished Investigators Nozomu Yachie, Nika Shakiba, and Josef Penninger.
https://www.eurekalert.org/news-releases/942653
NEWS RELEASE 9-FEB-2022
The Paul G. Allen Frontiers group announces 23 new Allen distinguished investigators
$15.5M in research funding will support cutting-edgeprojects in mammalian synthetic biology, the neuroscience of under-studied animals, and tiny proteins involved in immunity
Grant and Award Announcement
ALLEN INSTITUTE
Charting millions of unknown neurons in the octopus arm. Coaxing engineered mini-organs to grow their own blood vessels. Hunting down an ancient virus that appears to cause lupus. The latest cadre of Allen Distinguished Investigators is forging new ground in biomedical research.
The Paul G. Allen Frontiers Group, a division of the Allen Institute, today announced 11 awards of $1.3-1.5 million each to fund research projects led by 23 new Allen Distinguished Investigators. This is the largest single cohort of Allen Distinguished Investigators announced since the program’s inception and represents a total of $15.5 million in funding from the Paul G. Allen Family Foundation, as recommended by the Frontiers Group, to support cutting-edge, early-stage research projects that promise to advance the fields of biology and medicine.
The 11 awarded projects were selected from open calls for proposals in three fields: neural circuits of under-studied organisms, advances in mammalian synthetic biology, and micropeptides involved in immunity. To choose research areas that they recommend for funding, the Frontiers Group looks for emerging fields where an investment could be catalytic to advance scientific progress — not just for awardees, but for all in that particular field.
“We’re so excited about this new group of Allen Distinguished Investigators. They have transformative research visions and we’re thrilled to help bring those ideas to life,” said Kathy Richmond, Ph.D., M.B.A., Executive Vice President and Director of the Frontiers Group and the Office of Science and Technology at the Allen Institute. “They’re provocative and innovative with their approaches to science and with the ambitious goals they’ve set. They’re just fearless.”
The Allen Distinguished Investigator program was launched in 2010 by the late philanthropist Paul G. Allen to back creative, early-stage research projects in biology and medical research that would not otherwise be supported by traditional research funding programs. Including the new awards, a total of 105 Allen Distinguished Investigators have been appointed during the past 11 years. Each award spans three years of research funding.
Meet the new Allen Distinguished Investigators
The newly announced awards will fund three projects to understand the neurons that underlie movement in understudied animals; three projects to uncover how tiny, mysterious proteins known as micropeptides affect our immune systems; and five projects that seek to reimagine the field of synthetic biology through engineering mammalian tissues in the lab.
Neural Circuit Design
Researchers in the Neural Circuit Design cohort are studying evolutionary principles in the brain circuits that control movement, focusing on animals and systems that are not traditionally studied in the laboratory. Their studies will flesh out a more complete picture of the diversity of nervous systems and motor neural circuits in the animal kingdom, as well as pinpointing common and conserved principles of motion and motor control.
pt 1
Robyn Crook, Ph.D., is leading a project at San Francisco State University to study the neural control of movement in cephalopods, animals that have the most complicated nervous systems of the invertebrate world. She and her team will map the neural connections, or connectome, in the octopus arm and, for the first time, capture real-time neural activity in the octopus brain as the animal moves in natural ways.
Lucia Prieto-Godino, Ph.D., and Samuel Rodriques, Ph.D., are leading a project at The Francis Crick Institute to understand how a new kind of behavior arises in evolution. They will study brain cell types and circuits in larvae of a species of fruit fly that have evolved to jump 10 times their body length in the air, and then compare those to a related fruit fly species that cannot jump.
Where did modern nervous systems come from? Joseph Ryan, Ph.D., Mark Martindale, Ph.D., and James Strother, Ph.D., are leading a project at the Whitney Laboratory for Marine Bioscience to better understand the nervous systems of ctenophores, marine animals also known as comb jellies that represent one of the oldest branches of the animal kingdom. By mapping these evolutionarily ancient animals’ neural circuits and studying their neural development, the researchers will provide insight into the earliest animal nervous systems and shed light on general principles of modern brains.
Micropeptides and immunity
Our genomes contain vast amounts of DNA that remains poorly understood. A recent arrival on the scene of genomic “dark matter”: micropeptides, tiny proteins coded by tiny genes that had long escaped notice due to their size but that appear to be present in large number in our genome and that of every other living thing. These small molecules likely play roles in many different biological processes; scientists are recently uncovering their influence in several different diseases and in the function of the immune system. Scientists in the Micropeptides cohort are shedding new light on how micropeptides influence immunology, in health and in disease.
The human microbiome, the bacteria and other microbes that live in and on us, is inextricably interwoven with our health. Ami Bhatt, M.D., Ph.D., Michael Bassik, Ph.D., and Livnat Jerby, Ph.D., are leading a project at the Stanford University School of Medicine to look at the role of the gut microbiome’s micropeptides, tiny proteins that are themselves poorly understood, in human health and disease by studying how these micropeptides send signals to our immune cells.
pt 2
Robyn Crook, Ph.D., is leading a project at San Francisco State University to study the neural control of movement in cephalopods, animals that have the most complicated nervous systems of the invertebrate world. She and her team will map the neural connections, or connectome, in the octopus arm and, for the first time, capture real-time neural activity in the octopus brain as the animal moves in natural ways.
Lucia Prieto-Godino, Ph.D., and Samuel Rodriques, Ph.D., are leading a project at The Francis Crick Institute to understand how a new kind of behavior arises in evolution. They will study brain cell types and circuits in larvae of a species of fruit fly that have evolved to jump 10 times their body length in the air, and then compare those to a related fruit fly species that cannot jump.
Where did modern nervous systems come from? Joseph Ryan, Ph.D., Mark Martindale, Ph.D., and James Strother, Ph.D., are leading a project at the Whitney Laboratory for Marine Bioscience to better understand the nervous systems of ctenophores, marine animals also known as comb jellies that represent one of the oldest branches of the animal kingdom. By mapping these evolutionarily ancient animals’ neural circuits and studying their neural development, the researchers will provide insight into the earliest animal nervous systems and shed light on general principles of modern brains.
Micropeptides and immunity
Our genomes contain vast amounts of DNA that remains poorly understood. A recent arrival on the scene of genomic “dark matter”: micropeptides, tiny proteins coded by tiny genes that had long escaped notice due to their size but that appear to be present in large number in our genome and that of every other living thing. These small molecules likely play roles in many different biological processes; scientists are recently uncovering their influence in several different diseases and in the function of the immune system. Scientists in the Micropeptides cohort are shedding new light on how micropeptides influence immunology, in health and in disease.
The human microbiome, the bacteria and other microbes that live in and on us, is inextricably interwoven with our health. Ami Bhatt, M.D., Ph.D., Michael Bassik, Ph.D., and Livnat Jerby, Ph.D., are leading a project at the Stanford University School of Medicine to look at the role of the gut microbiome’s micropeptides, tiny proteins that are themselves poorly understood, in human health and disease by studying how these micropeptides send signals to our immune cells.
Pulin Li, Ph.D., is leading a project at the Whitehead Institute for Biomedical Research to improve the development of organoids, lab-grown mini-organs grown from human stem cells, by introducing a type of supportive tissue known as the stroma. Organoids that include a more complex and complete suite of tissues like the stroma may yield more information about human health and disease, as well as allow for rapid and accurate preclinical drug testing.
Adrian Ranga, Ph.D., is leading a project at KU Leuven to apply the emerging field of “soft robotics” to brain organoids, lab-grown mini-brains derived from human stem cells. Currently, brain organoids are missing several key structures and physical attributes of the real thing, which may be due in part to a lack of natural mechanical forces that shape and influence our developing brains. Ranga and his team will use newly developed materials and devices to stretch and fold brain organoids as they grow in the hopes of creating more life-like mini-brains for use in basic research and drug discovery.
Better understanding how human livers develop could allow researchers to grow new organs in the lab, filling a clinical need for transplantation for those with late-stage liver disease. Kelly Stevens, Ph.D., is leading a project at the University of Washington to explore the complete suite of factors involved in human liver development, including chemical cues, mechanical forces, blood supply and environmental factors.
pt 3
Wilson Wong, Ph.D., Chris Chen, M.D., Ph.D., and Darrell Kotton, M.D. are leading a project at Boston University to test a classic but unproven theory about how our lungs develop their complicated branching structures. The researchers will develop new tools to genetically engineer lung cells derived from human stem cells and attempt to recreate lung tissue’s complex branching in the lab. Ultimately, these tissues could be used in therapeutics for lung cancer and other lung diseases.
Nozomu Yachie, Ph.D., Nika Shakiba, Ph.D., and Josef Penninger, M.D., are leading a project at the University of British Columbia to trace the “family trees” of individual stem cells as they grow and divide into organoids, lab-grown mini-organs. Better understanding how organoid tissues are formed will help the scientists direct cell fates to more precisely engineer different kinds of organoids. The team is also working to introduce blood vessels into organoids to sustain their growth in the lab for longer.
About The Paul G. Allen Frontiers Group
The Paul G. Allen Frontiers Group, a division of the Allen Institute, is dedicated to exploring the landscape of bioscience to identify and foster ideas that will change the world. The Frontiers Group recommends funding to the Paul G. Allen Family Foundation, which then invests through award mechanisms to accelerate our understanding of biology, including: Allen Discovery Centers at partner institutions for leadership-driven, compass-guided research; and Allen Distinguished Investigators for frontier explorations with exceptional creativity and potential impact. The Paul G. Allen Frontiers Group was founded in 2016 by the late philanthropist and visionary Paul G. Allen. For more information, visit allenfrontiersgroup.org.
4 of 4
Not even close.
there is no "we" newfag. unbiased analysts support no one but truth. cops are on the energy of deception and the manifestation of dominion.
Shill? never been paid to post online ever. Who pays for truth? cops are enforcers of policy, government.
here is an old chunk of truth for your ignorant ass:
"The criminality of GLOBAL LEOs
These enforcers allow, enable, participate in, and profit from, cover up, and are otherwise complicit in VAST criminality.
Most will jump to say, "not all", or "I have cops in my family", or "I am a good guy/cop".
So ask them these two questions.
Whether they answer or not, you have seeded these rightfully tormenting thoughts in their consciousness:
Have you ever arrested a fellow LEO, politician, or so called elite in your jurisdiction when had they NOT been in one of those categories, you would have?
No cops, pols, or 'elite' beat their wives, drink and drive, touch kids, run hookers/drugs/etc, do hits, steal evidence, plant evidence, lie on reports, fudge numbers? Or just none during your entire career while you were on the clock.
Have you ever fabricated or planted evidence, accounts, or reports to close a case, get a warrant, augment charges, or knowlingly broken the rules or law for stats, promotion, vendetta, emotion, or any other reason? Never pinned open files on suspects who you knew where not the perp?
No other cops on shift with you, during your entire career did anythong like this that you were aware of or witnessed?
LEOs are much like the MSM, in that there are powers and pockets far bigger than their salaries and local lodges that will incentivise their criminality or willingness to be blind to in for certain populations.
Leadership in LEOs? You know the answer already…
How many incarcerated people are overcharged and oversentenced, unjustly charged, completely innocent, etc of crimes, due to the political pressure to 'lower crime' and increase arrests?
Law makers make more things criminal, always, as they are full time lawmakers. LEO are expected to drive revenue. This revenue comes from numbers. Arrests. Convictions. Court costs. Jail fees. DMV fees. Mandated treatment fees. Private prison contracts.
Gotta get that promotion! Fuck all of the lives ruined by this role in imprisoning unjustly, destroying families, future generations, etc.
The police in the USA started as the Slave Patrol. And it remains, 'citizen'.
Some say that No cop does the right thing-unless they QUIT. They will not be allowed by the blue wall. That is a GANG."
>28 posts at 600, calls truth shilling
I know, I am the one who held the camera, that you paid, forgetful nigga.